PLUS THERAPEUTICS, INC. — Director's Dealing 2022

Apr 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2022-04-27

Reporting Person: HEDRICK MARC H (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-26	Common Stock	P	2500	$0.6841	Acquired	28580	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.6841 or $0.6879 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.